Luteolin induces apoptosis by activating Fas signaling pathway at the receptor level in laryngeal squamous cell line Hep-2 cells
Authors:
- 30 January 2014
- journal article
- research article
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 271 (6) , 1653-1659
Abstract
Luteolin, a naturally occurring flavonoid, possesses anti-cancer activities against several human cancers, but the exact molecular and biochemical mechanisms of above findings are not very clear, and its activity against head and neck squamous cell carcinoma (HNSCC) is seldom mentioned. In this study, we investigated luteolin against human laryngeal squamous cell line Hep-2 cells, using MTT assay, flow cytometry, Western blot and reverse transcriptase–polymerase chain reaction (RT-PCR) analysis. Luteolin inhibited Hep-2 cells proliferation at the inhibitive concentrations of 50 % (IC50) near to 50 μM and induced the apoptosis in Hep-2 cells through caspase-3 and caspase-8 activation. Up-regulation of Fas and down-regulation of long form cellular FLICE-like inhibitory protein (c-FLIPL) protein were also involved after luteolin treatment at both protein and mRNA levels. Luteolin could not only inhibit cell proliferation but also induce apoptosis by activating the Fas signaling pathway at the receptor level in laryngeal squamous cell line Hep-2 cells.Keywords
This publication has 43 references indexed in Scilit:
- FLIP: A flop for execution signalsCancer Letters, 2013
- Anti-tumor Efficacy of a Recombinant Human Arginase in Human Hepatocellular CarcinomaCurrent Cancer Drug Targets, 2012
- Cdc2: a monopotent or pluripotent CDK?Cell Proliferation, 2011
- Effects of the Fas/Fas‐L pathway on fluoride‐induced apoptosis in SH‐SY5Y cellsEnvironmental Toxicology, 2011
- N,N-dimethyl phytosphingosine induces caspase-8-dependent cytochrome c release and apoptosis through ROS generation in human leukemia cellsToxicology and Applied Pharmacology, 2009
- The Fas Death Signaling Pathway Connecting Reactive Oxygen Species Generation and FLICE Inhibitory Protein Down-RegulationThe Journal of Immunology, 2008
- Cellular FLICE-like inhibitory protein (c-FLIP): A novel target for Taxol-induced apoptosisBiochemical Pharmacology, 2006
- NF-κB Inducers Upregulate cFLIP, a Cycloheximide-Sensitive Inhibitor of Death Receptor SignalingMolecular and Cellular Biology, 2001
- Phosphatidylinositol 3-Kinase/Akt Activity Regulates c-FLIP Expression in Tumor CellsJournal of Biological Chemistry, 2001
- T1‐T2 vocal cord carcinoma: A basis for comparing the results of radiotherapy and surgeryHead & Neck Surgery, 1988